Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)

Antibacterial Resistance Leadership Group (ARLG)

Research output: Contribution to journalComment/debate

Abstract

Volume 55, no. 1, p. 134-144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.

Original languageEnglish (US)
Pages (from-to)1970
Number of pages1
JournalJournal of clinical microbiology
Volume55
Issue number6
DOIs
StatePublished - Jun 2017

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)'. Together they form a unique fingerprint.

  • Cite this